The use of Elecsys PlGF and sFlt-1 test systems to predict perinatal outcomes in patients with severe preeclampsia
- Авторлар: Kurtser M.A1,2, Shamanova M.B1, Sinitsina O.V1, Nikolaev A.A1, Nikolaeva E.V1, Dedlovskaya A.I1, Samsonova M.A1
-
Мекемелер:
- Russian National Research Medical University named after N.I. Pirogov
- Group of Companies "Mother and Child”
- Шығарылым: № 10 (2019)
- Беттер: 162-171
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248714
- DOI: https://doi.org/10.18565/aig.2019.10.162-170
- ID: 248714
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
M. Kurtser
Russian National Research Medical University named after N.I. Pirogov; Group of Companies "Mother and Child”Academician of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology of the Pediatric Faculty, CEO of the Group of Companies “Mother and Child” Moscow, Russian Federation
M. Shamanova
Russian National Research Medical University named after N.I. Pirogov
Email: m.shamanova@mcdinics.ru
Head of the Laboratory Service Moscow, Sevastopolsky Avenue, 24, k1
O. Sinitsina
Russian National Research Medical University named after N.I. Pirogov
Email: o.sinitsina@mcclinics.ru
Head of the Clinical Diagnostic Laboratory Moscow region, Odintsovo district, 1st Uspenskoe highway, village Lapino, 111
A. Nikolaev
Russian National Research Medical University named after N.I. Pirogov
Email: a.nicolaev@mcclinics.ru
Head of the Clinical Diagnostic Laboratory Moscow region, Odintsovo district, 1st Uspenskoe highway, village Lapino, 111
E. Nikolaeva
Russian National Research Medical University named after N.I. Pirogov
Email: e.nikolaeva@mcclinics.ru
Head of the Clinical Diagnostic Laboratory Moscow, Sevastopolsky Avenue, 24, k1
A. Dedlovskaya
Russian National Research Medical University named after N.I. Pirogov
Email: a.dedlovskaya@mcclinics.ru
doctor obstetrician-gynecologist Moscow, Sevastopolsky Avenue, 24, k1
M. Samsonova
Russian National Research Medical University named after N.I. Pirogov
Email: ma.samsonova@mcclinics.ru
Clinical Resident Moscow, Sevastopolsky Avenue, 24, k1
Әдебиет тізімі
- Hernandez-Diaz S, Toh S., Cnattingius S. Risk of preeclamsia in ferst and subsequent pregnancies: prospective cohort study. BMJ. 2009; 338: b2255.
- Skjaerven R., Wilcox A.J., Lie R.T. The interval between pregnancies and the rrisk of preeclampsia. N. Engl. J. Med. 2002; 346(1): 33-8.
- Ananth C. V., Keyes K.M., Wapner R.J. Preeclamsia rates in the United States. 1980-2010: age-period-cohort analysis. BMJ. 2013; 347: f6564.
- Sibai B., Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365(9461): 785-99.
- Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA. 1993; 90(22): 10705-9.
- Lu F., Longo M., Tamayo E., Maner W., Al-Hendy A., Anderson G.D. et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am. J. Obstet. Gynecol. 2007; 196(4): 396. e1-7.
- Karumanchi S.A., Maynard S.E., Stillman I.E., Epstein F.H., Sukhatme V.P. Preeclampsia: a renal perspective. Kidney Int. 2005; 67(6): 2101-13.
- Zhang J., Klebanoff M.A., Roberts J.M. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet. Gynecol. 2001; 97(2): 261-7.
- Sibi B.M. Hypertension in pregnancy. In: Cabe S.G., Niebyl J.R., Simpson J.L., eds. Obstetrics: normal and problem pregnancies. 3rd ed. New York: Churchill Livingstone; 1996: 935-97.
- Page E.W, Christianson R Influence of blood pressure changes with and without proteiuria upon outcome of pregnancy. Am. J. Obstet. Gynecol. 1976; 126: 821-33.
- Zeisler H., Llurba E., Chantraine F., Vatish M., Staff A.C., Sennstrom M. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 2016; 374(1): 13-22.
- Курцер М.А., Шаманова М.Б., Синицина О.В., Николаев А.А., Дедловская А.И., Самсонова М.А. Клиническое обоснование определения соотношения sFlt-1/PlGF с целью раннего выявления и оценки степени тяжести преэклампсии. Акушерство и гинекология. 2018; 11: 114-20.
- Verlohren S., Herraiz I., Lapaire O., Schlembach D., Moertl M., Zeisler H. et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am. J. Obstet. Gynecol. 2012; 206(1): 58. e1-8.
- Gomez-Arriaga P.L., Herraiz I., Lopez-Jimenez E.A., Escribano D., Denk B., Galindo A. Uterine artery Doppler and sFlt-1/Plgf ratio: prognostic value in early-onset preeclampsia. Ultrasound Obstet. Gynecol. 2014; 43(5): 525-32.
- Meier E., Figueras F., Mula R., Crispi F., Benassar M., Gomes O., Gratacos E. Prognostic role of uterine artery Doppler in patients with preeclampsia. Fetal Diagn. Ther. 2010; 27: 8-13.
- Rana S., Powe C.E., Salahuddin S., Verlohren S., Perschel F.H., Levine R.J. et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclamsia. Circulation. 2012; 125(7): 911-9.
- Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). М.; 2016.
- Shear R.M., Rinfret D., Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? Am. J. Obstet. Gynecol. 2005; 192(4): 1119-25.
- Mitani M., Matsuda Y., Macino Y., Akizawa Y., Ohta H. Clinical features of fetal growth restriction complicated later by preeclampsia. J. Obstet. Gynaecol. Res. 2009; 35(5): 882-7.
- Benton S.J., Hu Y., Xie F., Kupfer K., Lee S. W., Magee L.A., von Dadelszen P. Can placental growth factor in maternal circulation identify fetses with placental intrauterine growth restriction? Am. J. Obstet. Gynecol. 2012; 206(2): 163. e1-7.
- Engineer N., Kumar S. Perinatal variables and neonatal outcomes in severey growth restricted preterm fetuses. Acta Obstet. Gynecol. Scand. 2010; 89(9): 1174-81.
- Garite T.J., Clark R., Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am. J. Obstet. Gynecol. 2004; 191(2): 481-7.
- Stolz M., Zeisler H., Heinzl F., Binder J., Farr A. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2018; 11: 54-60.
- Leanos-Miranda A., Mendez-Aguilar F., Ramirez-Valenzuela K.L., Serrano-RodriguezM., Berumen-Lechuga G., Molina-Perez C.J. et al. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes. Medicine (Baltimore). 2017; 96(4): e6005.